137 related articles for article (PubMed ID: 2841857)
1. Cutaneous herpes simplex virus lesions induced by ultraviolet radiation. A review of model systems and prophylactic therapy with oral acyclovir.
Spruance SL
Am J Med; 1988 Aug; 85(2A):43-5. PubMed ID: 2841857
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic acyclovir effectively reduces herpes simplex virus type 1 reactivation after exposure of latently infected mice to ultraviolet B.
Blatt AN; Laycock KA; Brady RH; Traynor P; Krogstad DJ; Pepose JS
Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3459-65. PubMed ID: 8225880
[TBL] [Abstract][Full Text] [Related]
3. Early intervention with high-dose acyclovir treatment during primary herpes simplex virus infection reduces latency and subsequent reactivation in the nervous system in vivo.
Sawtell NM; Thompson RL; Stanberry LR; Bernstein DI
J Infect Dis; 2001 Oct; 184(8):964-71. PubMed ID: 11574910
[TBL] [Abstract][Full Text] [Related]
4. Reactivation of latent herpes simplex virus infection by ultraviolet light: a human model.
Perna JJ; Mannix ML; Rooney JF; Notkins AL; Straus SE
J Am Acad Dermatol; 1987 Sep; 17(3):473-8. PubMed ID: 2821086
[TBL] [Abstract][Full Text] [Related]
5. Oral complications of cancer therapies. Management of acute viral infections.
Saral R
NCI Monogr; 1990; (9):107-10. PubMed ID: 2342587
[TBL] [Abstract][Full Text] [Related]
6. UV light-induced reactivation of herpes simplex virus type 2 and prevention by acyclovir.
Rooney JF; Straus SE; Mannix ML; Wohlenberg CR; Banks S; Jagannath S; Brauer JE; Notkins AL
J Infect Dis; 1992 Sep; 166(3):500-6. PubMed ID: 1323616
[TBL] [Abstract][Full Text] [Related]
7. A temporal analysis of acyclovir inhibition of induced herpes simplex virus type 1 In vivo reactivation in the mouse trigeminal ganglia.
Sawtell NM; Bernstein DI; Stanberry LR
J Infect Dis; 1999 Sep; 180(3):821-3. PubMed ID: 10438371
[TBL] [Abstract][Full Text] [Related]
8. [Clinical utility of susceptibility testing of herpes simplex virus to acyclovir].
Otegui M; Rabella N; Labeaga R; Herrero M; Margall N; Muñoz JM; Prats G
Rev Esp Quimioter; 2001 Dec; 14(4):351-7. PubMed ID: 11856981
[TBL] [Abstract][Full Text] [Related]
9. [Prevention and therapy of herpesvirus infections].
Abb J
Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
[TBL] [Abstract][Full Text] [Related]
10. Late relapse of herpes simplex virus encephalitis in a child due to reactivation of latent virus: clinicopathological report and review.
Spiegel R; Miron D; Yodko H; Lumelsky D; Habib A; Horovitz Y
J Child Neurol; 2008 Mar; 23(3):344-8. PubMed ID: 18230840
[TBL] [Abstract][Full Text] [Related]
11. Antiviral susceptibility of Herpes simplex viruses and its clinical correlates: a single center's experience.
Rabella N; Otegui M; Labeaga R; Rodríguez P; Margall N; Gurguí M; Prats G
Clin Infect Dis; 2002 Apr; 34(8):1055-60. PubMed ID: 11914993
[TBL] [Abstract][Full Text] [Related]
12. Acyclovir topical therapy of cutaneous herpes simplex virus infection in guinea pigs.
Park NH; Pavan-Langston D; McLean SL; Lass JH
Arch Dermatol; 1980 Jun; 116(6):672-5. PubMed ID: 7377804
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic chemotherapy with acyclovir for recurrent herpes simplex labialis.
Spruance SL
J Med Virol; 1993; Suppl 1():27-32. PubMed ID: 8245889
[TBL] [Abstract][Full Text] [Related]
14. Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation.
Dignani MC; Mykietiuk A; Michelet M; Intile D; Mammana L; Desmery P; Milone G; Pavlovsky S
Bone Marrow Transplant; 2002 Feb; 29(3):263-7. PubMed ID: 11859400
[TBL] [Abstract][Full Text] [Related]
15. Recurrent herpes simplex virus hepatitis after liver retransplantation despite acyclovir therapy.
Longerich T; Eisenbach C; Penzel R; Kremer T; Flechtenmacher C; Helmke B; Encke J; Kraus T; Schirmacher P
Liver Transpl; 2005 Oct; 11(10):1289-94. PubMed ID: 16184558
[TBL] [Abstract][Full Text] [Related]
16. [Perianal herpes simplex in a patient with Crohn's disease treated with infliximab].
López-Negre JL; Graells J; Orbeal R; Saavedra J; Parés D
Gastroenterol Hepatol; 2010 Dec; 33(10):758-9. PubMed ID: 20932602
[No Abstract] [Full Text] [Related]
17. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression.
Schacker T; Zeh J; Hu H; Shaughnessy M; Corey L
J Infect Dis; 2002 Dec; 186(12):1718-25. PubMed ID: 12447756
[TBL] [Abstract][Full Text] [Related]
18. The natural history of ultraviolet radiation-induced herpes simplex labialis and response to therapy with peroral and topical formulations of acyclovir.
Spruance SL; Freeman DJ; Stewart JC; McKeough MB; Wenerstrom LG; Krueger GG; Piepkorn MW; Stroop WG; Rowe NH
J Infect Dis; 1991 Apr; 163(4):728-34. PubMed ID: 1849159
[TBL] [Abstract][Full Text] [Related]
19. Pathogenicity and response to topical antiviral therapy in a murine model of acyclovir-sensitive and acyclovir-resistant herpes simplex viruses isolated from the same patient.
Lebel A; Boivin G
J Clin Virol; 2006 Sep; 37(1):34-7. PubMed ID: 16781887
[TBL] [Abstract][Full Text] [Related]
20. [Therapy of herpes simplex and varicella zoster infections in the ENT area].
Elies W; Hermes H; Schlöndorff G
Laryngol Rhinol Otol (Stuttg); 1987 Jan; 66(1):41-4. PubMed ID: 3031395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
